Safe S H
Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station 77843-4466, USA.
Environ Health Perspect. 1998 Aug;106 Suppl 4(Suppl 4):1051-8. doi: 10.1289/ehp.98106s41051.
There is considerable public, regulatory, and scientific concern regarding human exposure to endocrine-disrupting chemicals, which include compounds that directly modulate steroid hormone receptor pathways (estrogens, antiestrogens, androgens, antiandrogens) and aryl hydrocarbon receptor (AhR) agonists, including 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Based on quantitative structure-activity relationships for both AhR and estrogen receptor (ER) agonists, the relative potency (RP) of individual compounds relative to a standard (e.g. TCDD and 17-beta-estradiol) have been determined for several receptor-mediated responses. Therefore, the TCDD or estrogenic equivalent (TEQ or EQ, respectively) of a mixture is defined as TEQ = sigma[T(i)]xRP(i)or EQ=sigma[E(i)]xRP(i), where T(i) and E(i) are concentrations of individual AhR or ER agonists in any mixture. This approach for risk assessment of endocrine-disrupting mixtures assumes that for each endocrine response pathway, the effects of individual compounds are essentially additive. This paper will critically examine the utility of the TEQ/EQ approach for risk assessment, the validity of the assumptions used for this approach, and the problems associated with comparing low dose exposures to xeno and natural (dietary) endocrine disruptors.
公众、监管机构和科学界对人类接触内分泌干扰化学物质极为关注,这些物质包括直接调节类固醇激素受体途径的化合物(雌激素、抗雌激素、雄激素、抗雄激素)以及芳烃受体(AhR)激动剂,如2,3,7,8-四氯二苯并对二恶英(TCDD)及相关化合物。基于AhR和雌激素受体(ER)激动剂的定量构效关系,已针对多种受体介导的反应确定了各化合物相对于标准物(如TCDD和17-β-雌二醇)的相对效力(RP)。因此,混合物的TCDD或雌激素当量(分别为TEQ或EQ)定义为TEQ = ∑[T(i)]×RP(i) 或 EQ = ∑[E(i)]×RP(i),其中T(i)和E(i)是任何混合物中各AhR或ER激动剂的浓度。这种内分泌干扰混合物风险评估方法假定,对于每条内分泌反应途径,各化合物的影响基本是可加性的。本文将严格审视TEQ/EQ方法在风险评估中的实用性、该方法所用假设的有效性,以及比较低剂量接触外源和天然(饮食中的)内分泌干扰物所涉及的问题。